Skip to main content

XMFstockpicker

Peter Stephens

XMFstockpicker’s Activity

Wed Apr 16

NL

Article

TMFstockpicker published an article 10:04 AM

This Is Dividend Stock Johnson & Johnson’s Major Weakness

Although diversification can sometimes be a strength, it can also prove to be a double-edged sword in the long run. Here’s how.

Tue Apr 15

NL

Article

TMFstockpicker published an article 8:28 AM

Johnson & Johnson's 3 Major Strengths

What are the three key reasons why J&J could be a top performer in the future?

Wed Apr 2

NL

Article

TMFstockpicker published an article 1:22 PM

Can J&J's Pharma Segment Deliver Meaningful Growth?

In the final part of a three-part series, I take a deep dive into J&J's pharmaceuticals segment and ask whether it's as attractive as many investors believe.

Thu Mar 27

NL

Article

TMFstockpicker published an article 1:42 PM

Don't Underestimate J&J's Best-Known Products

In the second of a three-part series I take a closer look at J&J's (NYSE: JNJ) consumer segment to find out if it could make the stock take off.

Mon Mar 24

NL

Article

TMFstockpicker published an article 1:06 PM

Is J&J's Forgotten Half About to Take Off?

In the first of a three-part series, I put Johnson & Johnson's medical devices and diagnostics segment under the investment microscope.

Thu Mar 20

NL

Article

TMFstockpicker published an article 9:30 AM

Is Novartis' Strategy a Winning One?

Novartis has changed to a new strategy. Is it likely to be a successful one?

Wed Mar 19

NL

Article

TMFstockpicker published an article 9:30 AM

Better Buy: GlaxoSmithKline, AbbVie, or Merck?

Shares in GlaxoSmithKline have underperformed the index in recent years. Does this mean the stock is undervalued?

Tue Mar 18

NL

Article

TMFstockpicker published an article 4:52 PM

Is Procter & Gamble a Buy at Current Levels?

With shares disappointing in recent years, is Procter & Gamble now attractive?

NL

Article

TMFstockpicker published an article 3:16 PM

Why Philip Morris Could Be a Winning Stock

Philip Morris could be a strong performer in future. Here's why.

NL

Article

TMFstockpicker published an article 9:30 AM

Does Bristol-Myers Squibb Offer Good Value?

Having had a strong performance in recent years, does Bristol-Myers Squibb still offer good value for your money at current price levels?

Mon Mar 17

NL

Article

TMFstockpicker published an article 9:30 AM

Can Pfizer Outperform in 2014?

After tracking the index for five years, Pfizer could be worth buying. Here's why.

Fri Mar 14

NL

Article

TMFstockpicker published an article 6:30 PM

Can AbbVie Continue Its Bull Run?

After an impressive share price performance since it listed, is AbbVie still worth buying?

Thu Mar 13

NL

Article

TMFstockpicker published an article 9:30 AM

Can Eli Lilly Continue its Bull Run?

Despite some disappointing news, Eli Lilly's stock has made a strong start to 2014. Can it keep going?

Wed Mar 12

NL

Article

TMFstockpicker published an article 6:30 PM

Bristol-Myers Squibb: More Than Just a Relief Rally?

Shares in Bristol-Myers Squibb performed relatively positively last week. Can they keep it going?

Tue Mar 11

NL

Article

TMFstockpicker published an article 8:58 PM

Is Merck a Buy at Current Price Levels?

After a strong recent run, are shares in Merck (NYSE: MRK) still worth buying?

Sun Mar 9

NL

Article

TMFstockpicker published an article 7:00 AM

Has Celgene Corporation Run Out of Steam in 2014?

After an awesome 2013, Celgene (NASDAQ: CELG) has made a bad start to the year. Can it recover?

Fri Mar 7

NL

Article

TMFstockpicker published an article 1:48 PM

Can Merck Keep Its Bull Run Going?

Shares in Merck have made a strong start to 2014. Can they keep going?

Wed Mar 5

NL

Article

TMFstockpicker published an article 11:36 AM

Can Roche Keep Its Bull Run Going?

Despite mixed recent news flow, Roche remains a company with significant potential.

NL

Article

TMFstockpicker published an article 11:28 AM

Can Bristol-Myers Squibb Keep Its Bull Run Going in 2014?

The year 2013 was a great one for Bristol-Myers Squibb (NYSE: BMY); 2014 could also be a strong year due to a potential catalyst.

Tue Mar 4

NL

Article

TMFstockpicker published an article 2:53 PM

Can Pfizer Overcome Its Patent Woes?

With patent expiry causing pressure on sales, Pfizer (NYSE: PFE) is attempting an alternative response.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 59593
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 0
Best Pick ( 0)
Worst Pick ( 0)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to XMFstockpicker’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show XMFstockpicker’s 10 Latest Posts
The Motley Fool respects your privacy and strive to be transparent about our data collection practices. We use your information to customize the site for you, to contact you about your membership, provide you with promotional information, and in aggregate to help us better understand how the service is used. For more details, please review our Privacy Policy.